Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study

T.A.C. de Vries*, M.E.W. Hemels, F. Cools, H.J.G.M. Crijns, L. Yperzeele, P. Vanacker, I. Blankoff, P. Lancellotti, G.H. Mairesse, A. de Veer, R.C. Arroyo, E. Catez, M. de Pauw, T. Vanassche, C. de Asmundis, P. Kirchhof, R. De Caterina, J.R. de Groot, ETNA-AF-Europe principal investigators from Belgium and the Netherlands

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and the Netherlands: insights from the ETNA-AF-Europe study'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science